Pharmaceuticals

Revenue of the In Vivo Toxicology Market Predicted to Achieve $7.79 Billion by 2030, Driven by 6.7% CAGR

February 16, 2026March 11, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the in vivo toxicology market from 2026–2035 with trusted insights from The Business Research Company

What market expansion outlook does the In Vivo Toxicology Market show for the 2026–2030 period?

The in vivo toxicology market size has demonstrated significant growth in recent years. This market is set to expand from $5.61 billion in 2025 to $6 billion in 2026, registering a compound annual growth rate (CAGR) of 7.0%. Historically, this growth can be ascribed to factors including the restricted availability of standardized animal models, a dependence on manual laboratory procedures, increasing pharmaceutical R&D activities, the rising occurrence of chronic disease studies, and the adoption of basic imaging and analytical instruments.

The in vivo toxicology market size is projected to experience substantial expansion in the coming years, reaching $7.79 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.7%. This anticipated growth during the forecast period is due to factors such as the creation of genetically modified organisms for precise research, the incorporation of automated and high-throughput screening solutions, increased CRO outsourcing for toxicology assessments, progress in in vivo imaging and monitoring techniques, and a greater emphasis on alternative models along with the reduction of animal testing. Key developments expected in this period include the increased acceptance of rodent and non-human primate models, a growing need for sophisticated toxicology assay kits and reagents, the broadening of immunotoxicity and genotoxicity testing offerings, the wider implementation of automated liquid handling and imaging systems, and stricter regulatory adherence and ethical benchmarks in animal testing.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25791&type=smp

What Drivers Are Shaping The Development Of The In Vivo Toxicology Market?

The expanding volume of drug discoveries is projected to stimulate the growth of the in vivo toxicology market moving forward. Drug discovery entails the scientific identification and creation of new substances that can serve as therapies or preventive measures for various ailments. Progress in biotechnology has considerably boosted this endeavor by deepening the understanding of disease mechanisms and enabling the development of more targeted interventions. In vivo toxicology is indispensable in drug discovery, facilitating the evaluation of investigational compounds’ safety, tolerability, and potential adverse reactions within whole organisms. It aids in pinpointing dose-limiting toxicities and provides critical input for formulation and dosing strategies ahead of clinical development. For instance, in November 2024, according to the Patented Medicine Prices Review Board (PMPRB), a Canada-based government agency, over 12,000 new medicines were in clinical trials in 2023, an increase from around 9,000 in 2022, with oncology making up 33% of the pipeline, and infectious and central nervous system diseases comprising 13% and 12%, respectively. Therefore, the increasing pace of drug discoveries is a key factor propelling the expansion of the in vivo toxicology market.

What Segment Types Are Examined In The In Vivo Toxicology Market?

The in vivo toxicology market covered in this report is segmented –

1) By Product: Consumables, Instruments

2) By Testing Types: Chronic Toxicity Testing, Sub-Chronic Toxicity Testing, Sub-Acute Toxicity Testing, Acute Toxicity Testing

3) By Methodology: In Vivo Animal Models, Genetically Modified Organisms, Non-Human Primate Studies, Rodent Models, Larger Mammals

4) By Application: Immunotoxicity, Systemic Toxicity, Carcinogenicity, Genotoxicity, Developmental And Reproductive Toxicity (DART), Other Applications

5) By End-User: Pharmaceutical Companies, Biosimilars Manufacturers, Contract Research Organizations (CROs), Academic And Research Institutions, Biotechnology Firms

Subsegments:

1) By Consumables: Animal Models, Reagents And Kits, Assay Kits, Toxicology Testing Media, Antibodies, Biochemicals, Buffers And Solutions, Disposable Labware, Animal Feed, Diluents

2) By Instruments: Imaging Systems, Flow Cytometers, PCR Machines, Spectrophotometers, Microscopes, Analyzers, Centrifuges, Incubators, Animal Monitoring Systems, Automated Liquid Handling Systems

Which Trends Are Influencing The Development Of The In Vivo Toxicology Market?

Leading companies operating in the in vivo toxicology market are concentrating on creating advanced solutions, particularly secure cloud-based real-time data platforms, to streamline study management and enhance the speed of decision-making. These secure cloud-based real-time data platforms enable researchers and clients to access toxicology study data, milestones, planning tools, and various documents remotely and securely, thereby fostering improved collaboration and transparency. As an illustration, in March 2023, Charles River Laboratories International Inc., a US-based contract research organization, introduced Apollo, a secure cloud-based platform engineered to offer real-time access to toxicology study data. This secure, cloud-based platform is designed to support in vivo general toxicology studies, incorporating features for data visualization, planning, and milestone tracking. It facilitates faster and more informed decisions by providing instantaneous access to critical study data. The platform also assists in streamlining project planning and budget estimation throughout the drug development process. By digitizing toxicology workflows, Apollo considerably improves precision, efficiency, and collaboration in in vivo research.

Who Are The Core Companies Influencing Trends In The In Vivo Toxicology Market?

Major companies operating in the in vivo toxicology market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings (Labcorp), Sigma-Aldrich Co. LLC, Eurofins Scientific SE, Agilent Technologies Inc., WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Jubilant Life Sciences Limited, Evotec SE, The Jackson Laboratory, Inotiv Inc., Transcure Bioservices Pvt. Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/in-vivo-toxicology-global-market-report

Which Regions Are Projected To Dominate The In Vivo Toxicology Market In The Coming Years?

North America was the largest region in the in-vivo toxicology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vivo toxicology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized In Vivo Toxicology Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25791&type=smp

Browse Through More Reports Similar to the Global In Vivo Toxicology Market 2026, By The Business Research Company

In Vitro Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report

Adme Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report

Genetic Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795